Back to Market Feed

Product Information

DIPENTUM 250 MG CAPSULE is a brand product labeled by Viatris Specialty LLC, priced at $15.6962 per EA under NDC 00037686010. Its NADAC has been published 183 times since Jun 24, 2015.

FDA first approved this application on Jul 31, 1990.

DIPENTUM 250 MG CAPSULE

olsalazine sodium
$15.6962per EA

Strength

250 mg/1

NDC

00037686010

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Effective Date

1/1/2026

Active Ingredients

OLSALAZINE SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA019715

FDA Approved

7/31/1990

On Market Since

5/15/2015

Pharmacological Classes

Aminosalicylate
Aminosalicylic Acids

Price Statistics

The NADAC for DIPENTUM 250 MG CAPSULE has been published 183 times since Jun 24, 2015, and over the history we have for it it has risen 46.4%. The table below summarizes its recorded NADAC range and movement.

Current price$15.6962 per EA
All-time high$15.6962 (Aug 19, 2026)
All-time low$10.7208 (Jun 24, 2015)
52-week high$15.6962
52-week low$14.9488
Median price$14.2370
Average price$13.5024
Largest weekly change+15.3% (Oct 23, 2024)
Weeks tracked183
Tracking sinceJun 24, 2015

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+5.0%

3Y

+28.1%

5Y

+28.1%

All

+46.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olsalazine sodium market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

PENTASA 250 MG CAPSULE
Brand
54092018981•Takeda Pharmaceuticals America, Inc.
$2.9025
per EA
APRISO ER 0.375 GRAM CAPSULE
Brand
65649010302•Salix Pharmaceuticals Inc.
$4.0710
per EA
PENTASA 500 MG CAPSULE
Brand
54092019112•Takeda Pharmaceuticals America, Inc.
$5.8258
per EA
LIALDA DR 1.2 GM TABLET
Brand
54092047601•Takeda Pharmaceuticals America, Inc.
$8.9495
per EA
LIALDA DR 1.2 GM TABLET
Brand
54092047602•Takeda Pharmaceuticals America, Inc.
$8.9495
per EA
LIALDA DR 1.2 GM TABLET
Brand
54092047612•Takeda Pharmaceuticals America, Inc.
$8.9495
per EA
CANASA 1,000 MG SUPPOSITORY
Brand
58914050156•Allergan, Inc.
$37.0900
per EA
CANASA 1,000 MG SUPPOSITORY
Brand
58914050142•Allergan, Inc.
$37.0918
per EA

Frequently asked questions

What is the NADAC price of DIPENTUM 250 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DIPENTUM 250 MG CAPSULE, manufactured by Viatris Specialty LLC, is $15.6962 per EA (NDC 00037686010), effective Aug 19, 2026.

How has the price of DIPENTUM 250 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DIPENTUM 250 MG CAPSULE has risen 46.4%. It has been tracked across 183 weekly CMS publications since Jun 24, 2015.

What are the highest and lowest recorded NADAC prices for DIPENTUM 250 MG CAPSULE?

Since Jun 24, 2015, the NADAC for DIPENTUM 250 MG CAPSULE has ranged from a low of $10.7208 (Jun 24, 2015) to a high of $15.6962 (Aug 19, 2026), with a median of $14.2370 per EA.

Are there cheaper alternatives to DIPENTUM 250 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of DIPENTUM 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DIPENTUM 250 MG CAPSULE?

DIPENTUM 250 MG CAPSULE (NDC 00037686010) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.